Free Trial

Azenta, Inc. (NASDAQ:AZTA) Stake Cut by Teacher Retirement System of Texas

Azenta logo with Medical background

Teacher Retirement System of Texas reduced its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 99.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,040 shares of the company's stock after selling 662,516 shares during the period. Teacher Retirement System of Texas' holdings in Azenta were worth $209,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of AZTA. DAVENPORT & Co LLC increased its holdings in shares of Azenta by 4.1% during the 1st quarter. DAVENPORT & Co LLC now owns 27,438 shares of the company's stock valued at $950,000 after acquiring an additional 1,090 shares during the last quarter. Peregrine Capital Management LLC increased its holdings in shares of Azenta by 3.4% during the 1st quarter. Peregrine Capital Management LLC now owns 154,470 shares of the company's stock valued at $5,351,000 after acquiring an additional 5,093 shares during the last quarter. Lecap Asset Management Ltd. acquired a new position in shares of Azenta during the 1st quarter valued at about $669,000. Legacy Advisors LLC increased its holdings in shares of Azenta by 25.3% during the 1st quarter. Legacy Advisors LLC now owns 13,111 shares of the company's stock valued at $454,000 after acquiring an additional 2,649 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in shares of Azenta by 6.4% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 12,617 shares of the company's stock valued at $437,000 after acquiring an additional 756 shares during the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.

Azenta Stock Down 3.0%

Shares of Azenta stock opened at $31.16 on Monday. Azenta, Inc. has a 12 month low of $23.91 and a 12 month high of $63.58. The business has a fifty day simple moving average of $29.75 and a 200 day simple moving average of $36.35. The stock has a market cap of $1.43 billion, a PE ratio of -22.42 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same period in the prior year, the business earned $0.06 earnings per share. The firm's revenue was up 5.1% compared to the same quarter last year. Analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Evercore ISI raised their target price on Azenta from $29.00 to $35.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Needham & Company LLC reduced their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th.

View Our Latest Stock Report on AZTA

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines